3002410019
Novel coronavirus vaccine, not dosed or made into retail packaging
Declaration Elements
0: Brand type
1: Export benefits situation
2: Purpose:
3: Processing technology
4: Is the dosage prescribed
5: Is it retail packaging
6: Ingredients
7: Source:
8: Brand (Chinese or foreign name)
9: Model number
10: Packaging specifications
11:GTIN
12:CAS
13: Other
Customs Control Code
Customs Clearance Voucher for Imported Medicines
Customs Clearance Voucher for Entry Goods
Customs Clearance Voucher for Exit Goods
CIQ Category Code
On behalf of Entry Health Quarantine(或：Agent for Entry Health Quarantine)
On behalf of Exit Health Quarantine(或：Agent for Exit Health Quarantine)
By each trade agreement
RCEP
Directory
ChinaChina HS CodeSection 6Products of the chemical industry and related industries30medicine3002Human blood; Animal blood products used for disease treatment, prevention or diagnosis; Anti serum, other blood samples, and immune products, whether modified or processed through biological processes; Vaccines, toxins, cultured microorganisms (excluding yeast) and similar products; Cell cultures, whether modified or not300241Human vaccine30024100Human vaccine3002410019Novel coronavirus vaccine, not dosed or made into retail packagingCIQ
Novel coronavirus (COVID-19) vaccine, not dosed or made into retail packaging (for disease prevention)
Novel coronavirus (COVID-19) vaccine, not dosed or made into retail packaging (for medical research)
Disclaimer
The data on this page is sourced from publicly available information and is for reference only. It has no legal effect. Actual procedures should be based on the latest Import and Export Tariff Schedule and relevant laws and regulations issued by the General Administration of Customs.
